ADAR1 Capital Management »

Milestone Pharmaceuticals shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Milestone Pharmaceuticals (MIST) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Milestone Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Milestone Pharmaceuticals held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Milestone Pharmaceuticals by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $362k 203k 1.79

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Milestone Pharmaceuticals

BlackRock
Millennium Management
Alta Fundamental Advisers
Lion Point Capital
Citadel Advisors
OrbiMed Advisors
Nantahala Capital Management
Goldman Sachs Group
Bleichroeder
Altium Capital Management
Morgan Stanley
Velan Capital Investment Management
BML Capital Management
Monashee Investment Management
Ikarian Capital

View all funds holding Milestone Pharmaceuticals